BCRX BIOCRYST PHARMACEUTICALS INC
Nasdaq · SEC CIK 882796 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4.14M 8 sales by 4 insiders
- Filings on record
- 220 since 2021-07-19, latest 2026-09-02 16:16
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Barnes Alane P | CLO | — | $3.46M |
| HEGGIE THERESA | Dir | — | $504.8K |
| McKee Amy E | Dir | — | $100.3K |
| SANDERS MACHELLE | Dir | — | $68.5K |
| Menon Sandeep | Chief R, D Off | — | — |
| Ghias Babar | CFO | — | — |
| Gayer Charles K | Pres, CCO | — | — |
| Milne Jill C. | Dir | — | — |
| Frank Steven | Dir | — | — |
| Galson Steven K | Dir | — | — |
Transactions 263
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-09 | 2022-06-07 | BCRX | LEE KENNETH B JR | Dir | A - Grant | $0.00 | +12.9K | 37.1K | +53% | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | SANDERS MACHELLE | Dir | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $0.00 | +12.9K | 95.0K | +16% | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | Galson Steven K | Dir | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | Hutson Nancy J | Dir | A - Grant | $0.00 | +12.9K | 77.9K | +20% | $0 |
| D | 2022-06-09 | 2022-06-07 | BCRX | LEVIN ALAN G | Dir | A - Grant | $0.00 | +12.9K | 16.1K | +402% | $0 |
| 2022-06-02 | 2022-05-31 | BCRX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $9.31 | +2,078 | 82.1K | +3% | +$19.3K | |
| 2022-06-02 | 2022-05-31 | BCRX | LEVIN ALAN G | Dir | A - Grant | $9.31 | +1,138 | 3,197 | +55% | +$10.6K | |
| 2022-06-02 | 2022-05-31 | BCRX | ASELAGE STEVE | Dir | A - Grant | $9.31 | +569 | 33.7K | +2% | +$5,297 | |
| 2022-06-02 | 2022-05-31 | BCRX | HEGGIE THERESA | Dir | A - Grant | $9.31 | +1,138 | 17.4K | +7% | +$10.6K | |
| D | 2022-04-20 | 2022-04-18 | BCRX | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $11.04 | -5,000 | 0 | -100% | -$55.2K |
| D | 2022-04-20 | 2022-04-18 | BCRX | ABERCROMBIE GEORGE B | Dir | M - OptEx | $3.32 | +5,000 | 5,000 | New | +$16.6K |
| 2022-04-04 | 2022-04-01 | BCRX | Thackray Helen M. | Chief R, D Off | S - Sale | $16.20 | -7,600 | 136.4K | -5% | -$123.1K | |
| DM | 2022-03-14 | 2022-03-10 | BCRX | Sheridan William P | Chief Medical Off | S - Sale+OE | $16.88 | -161.1K | 38.0K | -81% | -$2.72M |
| D | 2022-03-14 | 2022-03-10 | BCRX | Sheridan William P | Chief Medical Off | M - OptEx | $3.22 | +148.3K | 199.1K | +292% | +$477.5K |
| 2022-03-09 | 2022-03-07 | BCRX | Babu Yarlagadda S | Chief Discovery Off | S - Sale | $17.16 | -20.0K | 230.1K | -8% | -$343.2K | |
| D | 2022-03-03 | 2022-03-01 | BCRX | Jones Michael L | Exec. Dir, Fin - PAO | S - Sale+OE | $17.20 | -2,300 | 11.2K | -17% | -$39.6K |
| D | 2022-03-03 | 2022-03-01 | BCRX | Jones Michael L | Exec. Dir, Fin - PAO | M - OptEx | $4.73 | +2,300 | 13.5K | +21% | +$10.9K |
| 2022-03-02 | 2022-02-28 | BCRX | HEGGIE THERESA | Dir | A - Grant | $16.61 | +602 | 16.2K | +4% | +$9,999 | |
| 2022-03-02 | 2022-02-28 | BCRX | ASELAGE STEVE | Dir | A - Grant | $16.61 | +301 | 33.2K | +0.9% | +$5,000 | |
| 2022-03-02 | 2022-02-28 | BCRX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $16.61 | +1,128 | 80.1K | +1% | +$18.7K | |
| 2022-03-02 | 2022-02-28 | BCRX | LEVIN ALAN G | Dir | A - Grant | $16.61 | +602 | 2,059 | +41% | +$9,999 | |
| D | 2022-02-16 | 2022-02-15 | BCRX | ABERCROMBIE GEORGE B | Dir | M - OptEx | $3.32 | +5,000 | 5,000 | New | +$16.6K |
| D | 2022-02-16 | 2022-02-15 | BCRX | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $18.50 | -5,000 | 0 | -100% | -$92.5K |
| A | 2022-01-13 | 2021-12-14 | BCRX | Barnes Alane P | CLO | A - Grant | $0.00 | +55.0K | 202.0K | +37% | $0 |
| D | 2022-01-13 | 2022-01-11 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | M - OptEx | $4.73 | +184.0K | 1.09M | +20% | +$870.3K |
| D | 2022-01-13 | 2022-01-11 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | S - Sale+OE | $15.04 | -184.0K | 901.6K | -17% | -$2.77M |
| A | 2022-01-13 | 2021-12-14 | BCRX | Doyle Anthony | CFO | A - Grant | $0.00 | +75.0K | 168.7K | +80% | $0 |
| A | 2022-01-13 | 2021-12-14 | BCRX | Gayer Charles K | Chief Commercial Off | A - Grant | $0.00 | +80.0K | 216.6K | +59% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Thackray Helen M. | Chief R, D Off | A - Grant | $0.00 | +44.0K | 144.0K | +44% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Jones Michael L | Exec. Dir, Fin - PAO | A - Grant | $0.00 | +5,850 | 11.2K | +109% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Barnes Alane P | CLO | A - Grant | $0.00 | +75.0K | 222.0K | +51% | $0 |
| DM | 2021-12-16 | 2021-09-01 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 778.6K | -1% | $0 |
| DMI | 2021-12-16 | 2021-09-01 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | G - Gift | $0.00 | +10.0K | 5,000 | New | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Stonehouse Jon P | Pres, CEO, Dir | A - Grant | $0.00 | +123.0K | 901.6K | +16% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Gayer Charles K | Chief Commercial Off | A - Grant | $0.00 | +125.0K | 261.6K | +92% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Babu Yarlagadda S | Chief Discovery Off | A - Grant | $0.00 | +35.0K | 250.1K | +16% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Sheridan William P | Chief Medical Off | A - Grant | $0.00 | +35.0K | 50.8K | +222% | $0 |
| D | 2021-12-16 | 2021-12-14 | BCRX | Doyle Anthony | CFO | A - Grant | $0.00 | +115.0K | 208.7K | +123% | $0 |
| D | 2021-12-09 | 2021-12-07 | BCRX | Babu Yarlagadda S | Chief Discovery Off | S - Sale+OE | $12.20 | -30.1K | 215.1K | -12% | -$367.2K |
| D | 2021-12-09 | 2021-12-07 | BCRX | Babu Yarlagadda S | Chief Discovery Off | M - OptEx | $4.73 | +62.0K | 245.2K | +34% | +$293.3K |
| 2021-12-02 | 2021-11-30 | BCRX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $12.06 | +1,554 | 78.9K | +2% | +$18.7K | |
| 2021-12-02 | 2021-11-30 | BCRX | ASELAGE STEVE | Dir | A - Grant | $12.06 | +414 | 32.9K | +1% | +$4,993 | |
| 2021-12-02 | 2021-11-30 | BCRX | LEVIN ALAN G | Dir | A - Grant | $12.06 | +829 | 1,457 | +132% | +$9,998 | |
| 2021-12-02 | 2021-11-30 | BCRX | HEGGIE THERESA | Dir | A - Grant | $12.06 | +829 | 15.6K | +6% | +$9,998 | |
| 2021-11-24 | 2021-11-24 | BCRX | MILANO VINCENT | Dir | P - Purchase | $12.19 | +7,500 | 17.5K | +75% | +$91.4K | |
| 2021-11-24 | 2021-11-23 | BCRX | Doyle Anthony | CFO | P - Purchase | $12.48 | +35.3K | 93.7K | +60% | +$440.0K | |
| D | 2021-11-17 | 2021-11-15 | BCRX | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $12.27 | -5,000 | 0 | -100% | -$61.4K |
| D | 2021-11-17 | 2021-11-15 | BCRX | ABERCROMBIE GEORGE B | Dir | M - OptEx | $3.32 | +5,000 | 5,000 | New | +$16.6K |
| DM | 2021-10-19 | 2021-10-15 | BCRX | Hutson Nancy J | Dir | M - OptEx | $3.46 | +105.0K | 170.1K | +161% | +$363.4K |
| D | 2021-10-19 | 2021-10-15 | BCRX | Hutson Nancy J | Dir | S - Sale+OE | $15.40 | -105.0K | 65.1K | -62% | -$1.62M |
| D | 2021-09-17 | 2021-09-15 | BCRX | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $15.06 | -5,000 | 0 | -100% | -$75.3K |
| D | 2021-09-17 | 2021-09-15 | BCRX | ABERCROMBIE GEORGE B | Dir | M - OptEx | $2.63 | +5,000 | 5,000 | New | +$13.2K |
| D | 2021-09-15 | 2021-09-13 | BCRX | LEE KENNETH B JR | Dir | S - Sale+OE | $15.35 | -6,000 | 24.3K | -20% | -$92.1K |
| D | 2021-09-15 | 2021-09-13 | BCRX | LEE KENNETH B JR | Dir | M - OptEx | $3.22 | +15.0K | 30.3K | +98% | +$48.3K |
| D | 2021-09-14 | 2021-09-10 | BCRX | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $15.09 | -74.0K | 0 | -100% | -$1.12M |
| DM | 2021-09-14 | 2021-09-10 | BCRX | ABERCROMBIE GEORGE B | Dir | M - OptEx | $2.86 | +71.0K | 74.0K | +2,367% | +$202.7K |
| 2021-09-02 | 2021-08-31 | BCRX | HEGGIE THERESA | Dir | A - Grant | $15.92 | +628 | 14.8K | +4% | +$9,998 | |
| 2021-09-02 | 2021-08-31 | BCRX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $15.92 | +1,177 | 77.4K | +2% | +$18.7K | |
| 2021-09-02 | 2021-08-31 | BCRX | LEVIN ALAN G | Dir | A - Grant | $15.92 | +628 | 628 | New | +$9,998 | |
| 2021-09-02 | 2021-08-31 | BCRX | ASELAGE STEVE | Dir | A - Grant | $15.92 | +314 | 32.4K | +1.0% | +$4,999 | |
| D | 2021-07-19 | 2021-07-15 | BCRX | ABERCROMBIE GEORGE B | Dir | S - Sale+OE | $15.69 | -5,000 | 3,000 | -62% | -$78.5K |
| D | 2021-07-19 | 2021-07-15 | BCRX | ABERCROMBIE GEORGE B | Dir | M - OptEx | $2.63 | +5,000 | 8,000 | +167% | +$13.2K |
Purchase Sale Sale after option exercise All abbreviations